Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Bionomous | 2024 | Debt Financing | $3.5M | Villaz-saint-pierre |
| Pelt8 | 2024 | Seed | Undisclosed | Zürich |
| Deegtal | 2025 | Grant | $809K | Geneva |
| Pulsewave | 2022 | Pre-Seed | $120K | Biel |
| REOR20 | 2025 | Grant | Undisclosed | Zürich |
| qCella | 2025 | Grant | Undisclosed | Zürich |
| csky.ai | 2025 | Grant | Undisclosed | Prilly |
| HeroSupport | 2025 | Grant | Undisclosed | Veyrier |
| Hemetron | 2025 | Grant | Undisclosed | Zürich |
| Fabas | 2025 | Grant | Undisclosed | Schlieren |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Bionomous | Debt Financing | $3.5M | Villaz-saint-pierre, Switzerland |
| 2 | Pelt8 | Seed | Undisclosed | Zürich, Switzerland |
| 3 | Deegtal | Grant | $809K | Geneva, Switzerland |
| 4 | Pulsewave | Pre-Seed | $120K | Biel, Switzerland |
| 5 | REOR20 | Grant | Undisclosed | Zürich, Switzerland |
| 6 | qCella | Grant | Undisclosed | Zürich, Switzerland |
| 7 | csky.ai | Grant | Undisclosed | Prilly, Switzerland |
| 8 | HeroSupport | Grant | Undisclosed | Veyrier, Switzerland |
| 9 | Hemetron | Grant | Undisclosed | Zürich, Switzerland |
| 10 | Fabas | Grant | Undisclosed | Schlieren, Switzerland |
Bionomous automates the screening, sorting, and plating of miniature biological entities to accelerating science
Pelt8 is a software company developing a cloud-based data collection platform, multiple reporting standards, and audit trails.
Deegtal is a technology company that provides solutions to enhance the efficiency and accuracy of epilepsy diagnosis.
Discreet and reliable remote patient monitoring with existing eyeglasses
SaaS, pre-event high fidelity flood risk assessment, post-event accurate flood analysis
qCella Impregnate natural fibers with copper and utilize them to create heating mats that outperform commercially available heating wires.
csky.ai specializes in using Edge AI technologies to enrich even the most sensitive discussions.
HeroSupport transforms imaging and/or treatment tables into personalized solutions.
Hemetron offers a handheld blood testing device that measures biomarkers for at‑home health monitoring and remote result sharing.
Fabas is an e-commerce website that offers food products like hummus, bean burgers, and falafel made from locally grown Swiss legumes.
Calvin Risk develops comprehensive and quantitative solutions to assess and manage the risks of AI algorithms in commercial use.
Oxara is a construction technology company that manufactures low carbon, circular, and healthy building materials for real estate projects.
Apheros is a metal foam cooling solutions company that offers a patent-pending easily scalable manufacturing approach for metal foams.
EDWATEC is at the forefront of developing Erbium-doped photonic integrated circuits for optical amplification on-chip.
Planeto is an energy transition company that engages in the design of sustainable district heating and cooling networks in buildings.
INERGIO is a reliable power power supply yet is a challenge to off-grid systems.
AMF Medical is a MedTech company that develops an Insulin Patch Pump.
AI Customer Service Platform for Enterprises
RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology.
Zaphiro has developed a real-time monitoring and automation system that enhances the efficiency and profitability of grid operations.
Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.
Mabylon develops novel antibody therapeutics in immunology & inflammation (I&I) and neurological disorders.
Librec provides technology for “closed-loop” recycling of large lithium-ion batteries from e-mobility.
At InnoSpina, we design and develop novel 3d printed implants and unique surgical guiding instruments to treat back pain in less than 30min
Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases
Innosuisse has invested in 211 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Innosuisse's top investment sectors include Health Care, Software, Medical, Medical Device, Manufacturing. The firm invests across 52 different industry categories.
Among tracked funding rounds, Mabylon received $18.6M in a Undisclosed round. Innosuisse's total known invested capital is $569.8M.
Innosuisse's average investment size is $3.2M across its portfolio of 211 companies.
Recent Innosuisse portfolio additions include Bionomous, Pelt8, Deegtal, Pulsewave, REOR20. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors